Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q3 FY26 results · Oct–Dec 2025
Amrutanjan Health Care reported revenue from operations of ₹141.04 crore (up 14.9% from Q3 FY25) and net profit of ₹19.45 crore (up 1.1% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a standalone basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 141.04 | 122.75 | +14.9% | 117.70 | +19.8% |
| Other income | 4.12 | 4.36 | −5.5% | 4.30 | −4.1% |
| Total income | 145.16 | 127.11 | +14.2% | 122.00 | +19.0% |
| Profit before tax | 26.36 | 25.99 | +1.4% | 19.21 | +37.2% |
| Net profit for the period | 19.45 | 19.25 | +1.1% | 13.96 | +39.3% |
| EPS, basic (₹) | 6.73 | 6.66 | +1.1% | 4.83 | +39.3% |
| Net margin (%) | 13.8 | 15.7 | 11.9 |
Standalone
- Filed with BSE
- 03 Feb 2026, 18:12 IST
- Board meeting
- 03 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE